Original article
Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway
El silenciamiento de HIF-1α agrava la esteatohepatitis no alcohólica in vitro a través de la inhibición de la vía de señalización PPAR-α/ANGPTL4
Yan He1, Wenhui Yang1, Lulu Gan, Shijie Liu, Qing Ni, Yunxia Bi, Tun Han, Qian Liu, Hongyan Chen, Yang Hu, Yun Long, Li Yang
Corresponding author
Yan’an Hospital Affiliated to Kunming Medical University, Yunnan Cardiovascular Hospital, Key Laboratory of Cardiovascular Disease of Yunnan Province, Heart Disease Clinical Medical Center of Yunnan Province, Elderly Cardiovascular Disease Technology Innovation Team of Kunming, Key Laboratory of Cancer immunodeficiency of Yunnan Province, Kunming, Yunnan, PR. China
Read
708
Timeswas read the article
101
Total PDF
607
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 38 | 5 | 43 |
| 2024 April | 42 | 6 | 48 |
| 2024 March | 66 | 8 | 74 |
| 2024 February | 57 | 10 | 67 |
| 2024 January | 47 | 6 | 53 |
| 2023 December | 45 | 3 | 48 |
| 2023 November | 60 | 6 | 66 |
| 2023 October | 85 | 11 | 96 |
| 2023 September | 29 | 7 | 36 |
| 2023 August | 32 | 1 | 33 |
| 2023 July | 20 | 1 | 21 |
| 2023 June | 33 | 5 | 38 |
| 2023 May | 26 | 4 | 30 |
| 2023 March | 2 | 0 | 2 |
| 2022 November | 3 | 3 | 6 |
| 2022 October | 5 | 5 | 10 |
| 2022 September | 4 | 4 | 8 |
| 2022 August | 5 | 7 | 12 |
| 2022 July | 1 | 1 | 2 |
| 2022 June | 2 | 2 | 4 |
| 2022 May | 1 | 0 | 1 |
| 2021 October | 0 | 4 | 4 |
| 2021 July | 1 | 0 | 1 |
| 2021 June | 2 | 0 | 2 |
| 2021 April | 1 | 2 | 3 |
Show all
